Weight loss and reduced body temperature determine humane endpoints in a mouse model of ocular herpesvirus infection

Journal of the American Association for Laboratory Animal Science

Volumn 52, Issue 3, 2013, Pages 277-285

  Hankenson, F Claire ^b   Ruskoski, Nicholas ^a   Van Saun, Marjorie ^b   Ying, Gui Shuang ^a   Oh, Jaewook ^a   Fraser, Nigel W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; EYE INFECTION; FEMALE; HERPES VIRUS INFECTION; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; THERMOMETRY; TRIGEMINUS GANGLION; VIRUS STRAIN; WEIGHT REDUCTION;

ANIMAL WELFARE; ANIMALS; BODY TEMPERATURE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA, VIRAL; EYE INFECTIONS; FEMALE; GUIDELINES AS TOPIC; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED BALB C; TRIGEMINAL GANGLION; VIRUS LATENCY; WEIGHT LOSS;

EID: 84877749514     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Aldred AJ, Cha MC, Meckling-Gill KA. 2002. Determination of a humane endpoint in the L1210 model of murine leukemia. Contemp Top Lab Anim Sci 41: 24-27.
2. Bast DJ, Yue M, Chen X, Bell D, Dresser L, Saskin R, Mandell LA, Low DE, de Azavedo JC. 2004. Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin. Antimicrob Agents Chemother 48: 3343-3348.
3. Bland JM, Altman DG. 1999. Measuring agreement in method comparison studies. Stat Methods Med Res 8: 135-160.
4. Brunell MK. 2012. Comparison of noncontact infrared thermometry and 3 commercial subcutaneous termperature transponding microchips with rectal thermometry in rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci 51: 479-484.
5. Carr DJ, Halford WP, Veress LA, Noisakran S, Perng GC, Wechsler SL. 1998. The persistent elevated cytokine mRNA levels in trigeminal ganglia of mice latently infected with HSV1 are not due to the presence of latency associated transcript (LAT) RNAs. Virus Res 54: 1-8.
6. Chen PH, White CE. 2006. Comparison of rectal, microchip transponder, and infrared thermometry techniques for obtaining body temperature in the laboratory rabbit (Oryctolagus cuniculus). J Am Assoc Lab Anim Sci 45: 57-63.
7. Clement C, Popp MP, Bloom DC, Schultz G, Liu L, Neumann DM, Bhattacharjee PS, Hill JM. 2008. Microarray analysis of host gene expression for comparison between naive and HSV1 latent rabbit trigeminal ganglia. Mol Vis 14: 1209-1221.
8. Clement JG, Mills P, Brockway B. 1989. Use of telemetry to record body temperature and activity in mice. J Pharmacol Methods 21: 129-140.
9. Franco NH, Correia-Neves M, Olsson IA. 2012. How 'humane' is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection. PLoS Pathog 8:e1002399.
10. Fraser NW, Correia-Neves M, Olsson IA. 1986. Molecular biology of latent HSV1, p 39-54. In: Lopez C, Roizman, B, editors. Human herpesvirus infections: pathobienesis, diagnosis, and treatment. New York (NY): Raven Press.
11. Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagy T, Natarajan R, Gesser RM. 1991. A review of the molecular mechanism of HSV1 latency. Curr Eye Res 10 Suppl: 1-13.
12. Hawkins P, Morton DB, Burman O, Dennison N, Honess P, Jennings M, Lane S, Middleton V, Roughan JV, Wells S, Westwood K. 2011. A guide to defining and implementing protocols for the welfare assessment of laboratory animals: 11th report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Lab Anim 45: 1-13.
13. Institute for Laboratory Animal Research. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academies Press.
14. Jiang X, Alami Chentoufi A, Hsiang C, Carpenter D, Osorio N, Benmohamed L, Fraser NW, Jones C, Wechsler SL. 2011. The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing. J Virol 85: 2325-2332.
15. Kastrukoff LF, Lau AS, Puterman ML. 1986. Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice. J Gen Virol 67: 613-621.
16. Kennedy PG, Al-Saadi SA, Clements GB. 1983. Reactivation of latent herpes simplex virus from dissociated identified dorsal root ganglion cells in culture. J Gen Virol 64: 1629-1635.
17. Kent JR, Fraser NW. 2005. The cellular response to herpes simplex virus type 1 (HSV1) during latency and reactivation. J Neurovirol 11: 376-383.
18. Koelle DM, Corey L. 2008. Herpes simplex: insights on pathogenesis and possible vaccines. Annu Rev Med 59: 381-395.
19. Kort WJ, Hekking-Weijma JM, TenKate MT, Sorm V, VanStrik R. 1998. A microchip implant system as a method to determine body temperature of terminally ill rats and mice. Lab Anim 32: 260-269.
20. Krarup A, Chattopadhyay P, Bhattacharjee AK, Burge JR, Ruble GR. 1999. Evaluation of surrogate markers of impending death in the galactosamine- sensitized murine model of bacterial endotoxemia. Lab Anim Sci 49: 545-550.
21. Kwiecien JM, Delaney KH. 2010. Endpoints in myelin-deficient (MD) rats. Comp Med 60: 343-347.
22. Madeddu P, Emanueli C, Spillmann F, Meloni M, Bouby N, Richer C, Alhenc-Gelas F, Van Weel V, Eefting D, Quax PH, Hu Y, Xu Q, Hemdahl AL, van Golde J, Huijberts M, de Lussanet Q, Struijker Boudier H, Couffinhal T, Duplaa C, Chimenti S, Staszewsky L, Latini R, Baumans V, Levy BI. 2006. Murine models of myocardial and limb ischemia: diagnostic endpoints and relevance to clinical problems. Vascul Pharmacol 45: 281-301.
23. Medina LV. 2004. How to balance humane endpoints, scientific data collection, and appropriate veterinary interventions in animal studies. Contemp Top Lab Anim Sci 43: 56-62.
24. Moccia KD, Olsen CH, Mitchell JM, Landauer MR. 2010. Evaluation of hydration and nutritional gels as supportive care after total-body irradiation in mice (Mus musculus). J Am Assoc Lab Anim Sci 49: 323-328.
25. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG. 2004. Humane endpoints in shock research. Shock 21: 17-25.
26. Newsom DM, Bolgos GL, Colby L, Nemzek JA. 2004. Comparison of body surface temperature measurement and conventional methods for measuring temperature in the mouse. Contemp Top Lab Anim Sci 43: 13-18.
27. Oh J, Fraser NW. 2008. Temporal association of the herpes simplex virus genome with histone proteins during a lytic infection. J Virol 82: 3530-3537.
28. Paster EV, Villines KA, Hickman DL. 2009. Endpoints for mouse abdominal tumor models: refinement of current criteria. Comp Med 59: 234-241.
29. Perng GC, Dunkel EC, Geary PA, Slanina SM, Ghiasi H, Kaiwar R, Nesburn AB, Wechsler SL. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV1) is required for the efficient in vivo spontaneous reactivation of HSV1 from latency. J Virol 68: 8045-8055.
30. Perng GC, Jones C. 2010. Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis 2010:262415.
31. Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina SM, Hofman FM, Ghiasi H, Nesburn AB, Wechsler SL. 2000. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287: 1500-1503.
32. Perng GC, Slanina SM, Yukht A, Drolet BS, Keleher W Jr, Ghiasi H, Nesburn AB, Wechsler SL. 1999. A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J Virol 73: 920-929.
33. Phillips PM, Jarema KA, Kurtz DM, MacPhail RC. 2010. An observational assessment method for aging laboratory rats. J Am Assoc Lab Anim Sci 49: 792-799.
34. Ray MA, Johnston NA, Verhulst S, Trammell RA, Toth LA. 2010. Identification of markers for imminent death in mice used in longevity and aging research. J Am Assoc Lab Anim Sci 49: 282-288.
35. Russell WMS, Burch RL. 1959. The principles of humane experimental technique. Methuen (MA): Nature.
36. Soothill JS, Morton DB, Ahmad A. 1992. The HID50 (hypothermia- inducing dose 50): an alternative to the LD50 for measurement of bacterial virulence. Int J Exp Pathol 73: 95-98.
37. Spivack JG, Fraser NW. 1988. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J Virol 62: 1479-1485.
38. Toth LA. 2000. Defining the moribund condition as an experimental endpoint for animal research. ILAR J 41: 72-79.
39. Toth LA, Rehg JE, Webster RG. 1995. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J Neuroimmunol 58: 89-99.
40. Trammell RA, Cox L, Toth LA. 2012. Markers for heightened monitoring, imminent death, and euthanasia in aged inbred mice. Comp Med 62: 172-178.
41. Trammell RA, Toth LA. 2011. Markers for predicting death as an outcome for mice used in infectious disease research. Comp Med 61: 492-498.
42. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR. 2008. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780- 783.
43. Vlach KD, Boles JW, Stiles BG. 2000. Telemetric evaluation of body temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock. Comp Med 50: 160-166.
44. Walz MA, Yamamoto H, Notkins AL. 1976. Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature 264: 554-556.
45. Warn PA, Brampton MW, Sharp A, Morrissey G, Steel N, Denning DW, Priest T. 2003. Infrared body temperature measurement of mice as an early predictor of death in experimental fungal infections. Lab Anim 37: 126-131.
46. Wong JP, Saravolac EG, Clement JG, Nagata LP. 1997. Development of a murine hypothermia model for study of respiratory tract influenza virus infection. Lab Anim Sci 47: 143-147.